drugset / Trial / NCT01131325
Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma Concentrations
NaSingle-groupOpen-labelTreatment
Summary
This study is to determine the number of European Leukemia Network (ELN)guideline defined treatment failure events from time of study entry in CML-CP patients with low imatinib trough concentrations treated with nilotinib.
Timeline
- Start
- 2010-10-21
- Primary completion
- 2011-05-12
- Completion
- 2011-05-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nilotinib | Small molecule | 300 mg | Oral |